|
GTF2H3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.425590E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.170200E-02 |
| Normal-vs-Stage2 |
7.869800E-01 |
| Normal-vs-Stage3 |
9.169000E-01 |
| Normal-vs-Stage4 |
3.144600E-01 |
| Stage1-vs-Stage2 |
4.218400E-01 |
| Stage1-vs-Stage3 |
1.989160E-01 |
| Stage1-vs-Stage4 |
8.986600E-01 |
| Stage2-vs-Stage3 |
7.831400E-01 |
| Stage2-vs-Stage4 |
5.023000E-01 |
| Stage3-vs-Stage4 |
4.054600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.193990E-01 |
| Normal-vs-AfricanAmerican |
3.585200E-01 |
| Normal-vs-Asian |
3.671400E-01 |
| Caucasian-vs-AfricanAmerican |
8.097600E-01 |
| Caucasian-vs-Asian |
6.873400E-01 |
| AfricanAmerican-vs-Asian |
5.942200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.102080E-02 |
| Normal-vs-Female |
2.148000E-01 |
| Male-vs-Female |
8.768100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.338200E-02 |
| Normal-vs-Extreme_Weight |
1.036370E-03 |
| Normal-vs-Obese |
9.817200E-01 |
| Normal-vs-Extreme_Obese |
3.186000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.005800E-01 |
| Normal_Weight-vs-Obese |
1.426570E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.649200E-01 |
| Extreme_Weight-vs-Obese |
1.665950E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.493800E-01 |
| Obese-vs-Extreme_Obese |
3.371600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.373800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.728600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.663700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.997800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.412570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.644300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.705700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.248600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.767180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.261800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.616400E-02 |
| Normal-VS-Type2 PRCC |
4.240000E-01 |
| Normal-VS-KIRP CIMP |
3.354000E-01 |
| Normal-VS-Unclassified PRCC |
7.201400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.672000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.381700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.292300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.691380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.991200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.988600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.133840E-02 |
| Normal-vs-N1 |
3.088800E-01 |
| Normal-vs-N2 |
6.869600E-01 |
| N0-vs-N1 |
2.923500E-02 |
| N0-vs-N2 |
7.095600E-01 |
| N1-vs-N2 |
4.739200E-01 |
|
|
